MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Drugs.com - Pharma News' source. Sat, 20 Mar 2010 15:04:09 +0100 http://www.medworm.com/index.php?rid=3384610&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FhaFB6HGusWk%2Ffda-warns-increased-risk-muscle-injury-zocor-23311.html Highest approved dose of cholesterol-lowering medication could cause harm to muscles SILVER SPRING, Md., March 19 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today warned patients and healthcare providers about the potential for... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3384610 Fri, 19 Mar 2010 19:16:13 +0100 3384610 http://www.medworm.com/index.php?rid=3381170&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fh3MJiMVXaoI%2Flilly-discloses-full-list-conn-theft-23299.html From Associated Press (March 18, 2010) INDIANAPOLIS -- Drug maker Eli Lilly and Co. said that thieves who broke into one of its warehouses over the weekend made off with drugs including the cancer treatments Alimta and Gemzar, and the blood thinner... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3381170 Fri, 19 Mar 2010 14:05:22 +0100 3381170 http://www.medworm.com/index.php?rid=3381171&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F7asgYT-8fqs%2Ftheravance-falls-relovair-comments-stock-offer-23298.html From Associated Press (March 18, 2010) NEW YORK -- Shares of Theravance Inc. slid Thursday after the drug developer announced a stock offering and said it is not sure what regulators want to see in late-stage clinical trials of its asthma drug... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3381171 Fri, 19 Mar 2010 14:05:04 +0100 3381171 http://www.medworm.com/index.php?rid=3381172&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fk2qhl4jPm5I%2Fpfizer-s-jeffrey-kindler-becomes-phrma-board-chairman-christopher-viehbacher-john-lechleiter-assume-23302.html WASHINGTON, March 18 /PRNewswire-USNewswire/ -- Jeffrey B. Kindler, Chairman and Chief Executive Officer, Pfizer, was elected board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association's annual... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3381172 Fri, 19 Mar 2010 14:04:54 +0100 3381172 http://www.medworm.com/index.php?rid=3381173&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FeDtqoGw6Zl0%2Fscientists-ties-industry-more-likely-write-nice-things-23300.html From Canadian Press DataFile (March 18, 2010) TORONTO -- Medical authors with ties to diabetes drug makers were more likely to publish favourable articles on a controversial diabetes medication than authors who had no such ties, a new... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3381173 Fri, 19 Mar 2010 13:58:45 +0100 3381173 http://www.medworm.com/index.php?rid=3381174&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FXSEG1ynRAGc%2Fpfizer-scientists-collaborating-new-tb-initiative-23301.html [The Day, New London, Conn.] From Day, The (New London, CT) (March 19, 2010) Mar. 18--Pfizer Inc. scientists in Groton are joining a worldwide collaboration to find a new drug regimen to... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3381174 Fri, 19 Mar 2010 13:58:23 +0100 3381174 http://www.medworm.com/index.php?rid=3381175&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FjG3_axCgBKU%2Fastellas-meets-antitrust-mark-osi-attempt-23297.html From Associated Press (March 19, 2010) NEW YORK, March 19, 2010 -- Japanese drug maker Astellas Pharma Inc. said Friday a federal antitrust waiting period expired in regard to its $3.5 billion takeover bid for OSI Pharmaceuticals Inc.... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3381175 Fri, 19 Mar 2010 13:51:50 +0100 3381175 http://www.medworm.com/index.php?rid=3376432&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FJEd9HtuFhno%2Froche-uniquely-positioned-deliver-long-term-growth-23274.html Leading late-stage pipeline and innovation strategy presented at investor conference BASEL, Switzerland, March 18, 2010-Roche (SIX: RO, ROG; OTCQX: RHHBY) is set to strengthen its global leadership position in oncology and to expand in... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3376432 Thu, 18 Mar 2010 14:40:49 +0100 3376432 http://www.medworm.com/index.php?rid=3376433&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fc3_EecS-mpo%2Fnovelos-therapeutics-discontinues-current-development-program-nov-002-nsclc-23275.html NOV-002 Phase 2 Development Continues in Breast Cancer Indication; Seeking to Build Clinical Stage Oncology Pipeline NEWTON, Mass.--(BUSINESS WIRE)--Mar 18, 2010 - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3376433 Thu, 18 Mar 2010 14:33:36 +0100 3376433 http://www.medworm.com/index.php?rid=3376434&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FC5wgX9oJmX0%2Fteva-acquire-ratiopharm-23276.html Combined Entity Creates New Market Leader in European Generics Acquisition Expected to be Accretive within Three Quarters after Closing Company to Host Conference Call at 8:30 AM ET JERUSALEM--(BUSINESS WIRE)--Mar 18, 2010 - Teva Pharmaceutical... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3376434 Thu, 18 Mar 2010 14:23:30 +0100 3376434 http://www.medworm.com/index.php?rid=3376435&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FocpYY8u7R1c%2Fmaine-house-oks-back-plan-23273.html AUGUSTA, Maine -- Traces of old and unused medications that people throw out with the trash are showing up in water, and Maine lawmakers took a step Wednesday toward reversing the problem -- at the expense of the pharmaceutical industry. By a 91-51... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3376435 Thu, 18 Mar 2010 12:55:57 +0100 3376435 http://www.medworm.com/index.php?rid=3376437&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fwvhe6SGIRDg%2Fsuspends-vaccine-sanofi-aventis-subsidiary-because-white-sediment-inside-vials-23272.html GENEVA -- The U.N. health agency said Wednesday it has suspended its approval of a vaccine against tetanus and four other diseases produced by Sanofi-Aventis SA subsidiary because of a white substance forming inside some vials. The World Health... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3376437 Thu, 18 Mar 2010 12:55:27 +0100 3376437 http://www.medworm.com/index.php?rid=3376436&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FhpAm52O8DKk%2Ffda-asks-consumers-submit-questions-part-transparency-plan-23271.html Mar. 17--So how and when does the Food and Drug Administration decide to pull a prescription from the market? Should I be asking whether my doctor accepts gifts or sandwiches from drug companies? Why are drug makers notified by the FDA when a device... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3376436 Thu, 18 Mar 2010 12:55:27 +0100 3376436 http://www.medworm.com/index.php?rid=3376438&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FtF2pzdLCny4%2Fims-announces-17-countries-now-rank-growth-pharmerging-markets-forecast-contribute-nearly-industry-23259.html China to Become World's Third-Largest Pharmaceutical Market Next Year NORWALK, Conn.--(BUSINESS WIRE)--Mar 16, 2010 - IMS Health today announced that 17 high-growth pharmaceutical markets are now ranked as “pharmerging,” up from seven... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3376438 Tue, 16 Mar 2010 20:04:22 +0100 3376438 http://www.medworm.com/index.php?rid=3372404&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FXLviCdEjM_M%2Ftekmira-pfizer-initiate-new-research-collaboration-23235.html Vancouver, BC, March 16, 2010— Tekmira Pharmaceuticals Corporation (TSX: TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today the initiation of a new research collaboration with Pfizer (NYSE: PFE). Tekmira and... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3372404 Tue, 16 Mar 2010 16:21:35 +0100 3372404 http://www.medworm.com/index.php?rid=3372406&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FHkmRQO2iEoI%2Fmylan-takeda-reach-agreement-over-diabetes-23237.html From Associated Press (March 16, 2010) PITTSBURGH -- Generic drug maker Mylan Inc. has reached settlement agreements with Japanese drug maker Takeda Pharmaceuticals over rights to launch generic versions of two Type 2 diabetes treatments. Mylan... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3372406 Tue, 16 Mar 2010 16:15:13 +0100 3372406 http://www.medworm.com/index.php?rid=3372405&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FHTCnlWvcRDU%2Fformer-employee-fired-refusing-return-work-pfizer-maintains-civil-case-scientist-says-dismissal-23236.html Former Employee Fired For Refusing To Return To Work, Pfizer Maintains: In Civil Case, Scientist Says Dismissal Was Retaliation [The Day, New London, Conn.] From Day, The (New London, CT) (March 16, 2010) Mar. 16--HARTFORD -- A former Pfizer Inc.... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3372405 Tue, 16 Mar 2010 16:15:13 +0100 3372405 http://www.medworm.com/index.php?rid=3372407&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FbHM9FeGqX9U%2Flilly-signs-licensing-pact-testosterone-aid-23238.html From Indianapolis Star (IN) (March 16, 2010) Mar. 16--Eli Lilly and Co., which found success with its erectile-dysfunction drug Cialis , is taking steps that could lead to the launch of another men’s health product. The Indianapolis drug maker... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3372407 Tue, 16 Mar 2010 16:14:56 +0100 3372407 http://www.medworm.com/index.php?rid=3372408&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FQpziCffUecQ%2Fallergan-inc-announces-juvederm-switch-up-campaign-educating-women-positive-impact-small-changes-23239.html Television personality Dayna Devon embraces turning 40 this year and is sharing personal tips on how women can keep their look fresh to portray their best selves IRVINE, Calif., March 16 /PRNewswire-FirstCall/ -- Allergan, Inc. (NYSE: AGN) has... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3372408 Tue, 16 Mar 2010 16:05:44 +0100 3372408 http://www.medworm.com/index.php?rid=3368480&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FZgqhx_GgH1o%2Fcline-davis-amp-mann-announces-expansion-cdm-world-agency-paris-milan-montreal-23211.html NEW YORK, March 15, 2010--Cline Davis & Mann (CDM), the world’s leading healthcare communications services company, announced the expansion of CDM World Agency, through the acquisition of market-leading agencies in Paris, Milan... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3368480 Mon, 15 Mar 2010 19:40:15 +0100 3368480 http://www.medworm.com/index.php?rid=3368481&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FO-QC9Be9kb8%2Fastellas-responds-osi-pharmaceuticals-rejection-23212.html Astellas' All-Cash Offer Provides Immediate, Full Value to OSI Stockholders TOKYO, March 15 /PRNewswire/ -- Astellas Pharma Inc. today released the following statement in response to OSI Pharmaceuticals' (NASDAQ: OSIP) rejection of Astellas'... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3368481 Mon, 15 Mar 2010 19:27:15 +0100 3368481 http://www.medworm.com/index.php?rid=3365091&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FOmirDqsr01M%2Fosi-pharmaceuticals-board-directors-unanimously-rejects-astellas-unsolicited-tender-offer-23203.html Board Concludes Offer Does Not Fully Reflect OSI's Fundamental, Intrinsic Value Board Recommends Stockholders Not Tender Shares at $52.00 per Share Company, With Assistance of Financial Advisors, to Contact Third Parties   MELVILLE,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3365091 Mon, 15 Mar 2010 13:45:16 +0100 3365091 http://www.medworm.com/index.php?rid=3365092&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FaVQWdVdt9Ko%2Ffda-asks-risk-plan-info-diabetes-23204.html From Associated Press (March 15, 2010) SAN DIEGO -- Amylin Pharmaceuticals Inc. said Monday it received a Food and Drug Administration request for information on manufacturing and a risk mitigation plan for a potential once-weekly diabetes... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3365092 Mon, 15 Mar 2010 13:25:59 +0100 3365092 http://www.medworm.com/index.php?rid=3365093&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FVBBVHbcd5N8%2Famylin-lilly-alkermes-receive-complete-response-letter-fda-exenatide-once-weekly-submission-23197.html BYDUREON™ (exenatide for extended-release injectable suspension) Proposed Name SAN DIEGO & INDIANAPOLIS & WALTHAM, Mass.--(BUSINESS WIRE)--Mar 15, 2010 - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY)... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3365093 Mon, 15 Mar 2010 11:56:48 +0100 3365093 http://www.medworm.com/index.php?rid=3361265&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FkEwcMMWGZqQ%2Ffda-announces-new-boxed-warning-plavix-23176.html SILVER SPRING, Md., March 12 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3361265 Fri, 12 Mar 2010 18:50:03 +0100 3361265 http://www.medworm.com/index.php?rid=3361266&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FXN0VqIZs398%2Fmiddlebrook-pharmaceuticals-reports-fourth-quarter-2009-full-year-results-announces-reduction-force-23177.html WESTLAKE, Texas--(BUSINESS WIRE)--Mar 12, 2010 - MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is further restructuring to reduce expenses, and that it is evaluating strategic... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3361266 Fri, 12 Mar 2010 18:36:21 +0100 3361266 http://www.medworm.com/index.php?rid=3361267&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FClODfkk1jbY%2Fsanofi-aventis-bristol-myers-squibb-announce-important-updates-plavix-u-s-23178.html BRIDGEWATER, N.J. & PRINCETON, N.J.--(BUSINESS WIRE)--Mar 12, 2010 - Sanofi-aventis U.S. and Bristol-Myers Squibb Company (NYSE: BMY) today announced revisions to the U.S. prescribing information for PLAVIX® (clopidogrel bisulfate),... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3361267 Fri, 12 Mar 2010 18:35:49 +0100 3361267 http://www.medworm.com/index.php?rid=3361268&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FdFnB51bXwxc%2Fglaxosmithkline-makes-vaccine-executive-changes-23166.html From Associated Press (March 12, 2010) LONDON -- British pharmaceutical company GlaxoSmithKline PLC on Friday announced two changes in the executive lineup of its vaccines business. Jean Stephenne was appointed chairman of GSK Biologicals with... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3361268 Fri, 12 Mar 2010 15:57:13 +0100 3361268 http://www.medworm.com/index.php?rid=3356863&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F916gxBcf0pA%2Fintellipharmaceutics-announces-settlement-version-focalin-xr-23161.html TORONTO, March 11, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3356863 Fri, 12 Mar 2010 13:43:18 +0100 3356863 http://www.medworm.com/index.php?rid=3356864&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fxwzd5SbVJ14%2Ffda-no-clear-evidence-linking-bisphosphonates-fractures-23159.html From BioWorld Today (March 12, 2010) WASHINGTON - After headlines emerged Wednesday about new data linking prolonged bisphosphonate use to an increased risk of atypical femur fractures, the FDA rushed to assure prescribers and the public that the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3356864 Fri, 12 Mar 2010 13:30:11 +0100 3356864 http://www.medworm.com/index.php?rid=3356865&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FisUakFgsoF4%2Fmerck-provides-update-improve-trial-23162.html WHITEHOUSE STATION, N.J., March 11, 2010 -- Merck & Co., Inc. today said that the Data Safety Monitoring Board (DSMB) of the IMPROVE-IT study has performed a pre-specified interim analysis of efficacy data and also reviewed safety data from the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3356865 Fri, 12 Mar 2010 12:53:54 +0100 3356865 http://www.medworm.com/index.php?rid=3356866&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FSkg4Lg-sXLU%2Fgenentech-says-avastin-trial-did-not-meet-goal-23160.html From Associated Press (March 12, 2010) NEW YORK -- Roche’s efforts to win new marketing approvals for a cancer treatment candidate hit another stumbling block Friday as the Swiss drugmaker said Avastin did not improve survival among prostate... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3356866 Fri, 12 Mar 2010 12:40:09 +0100 3356866 http://www.medworm.com/index.php?rid=3356867&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FTYySOzOEjj0%2Fpfizer-ends-study-potential-lung-cancer-23163.html From Associated Press (March 11, 2010) NEW YORK -- Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness. The company said an... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3356867 Fri, 12 Mar 2010 12:25:17 +0100 3356867 http://www.medworm.com/index.php?rid=3356868&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F610vy-nq0jc%2Fpfizer-says-sutent-fails-breast-cancer-studies-23164.html From Associated Press (March 11, 2010) NEW YORK -- Pfizer Inc. said Thursday the cancer drug Sutent did not meet key goals in two late-stage studies focusing on advanced breast cancer. The drug is already sold as a treatment for advanced... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3356868 Fri, 12 Mar 2010 12:17:09 +0100 3356868 http://www.medworm.com/index.php?rid=3356869&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F0FEfeEd3vO4%2Fpfizer-ends-study-potential-lung-cancer-23165.html From Associated Press (March 11, 2010) NEW YORK -- Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness. The company said an... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3356869 Fri, 12 Mar 2010 12:16:50 +0100 3356869 http://www.medworm.com/index.php?rid=3356870&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FpYpzhShczk8%2Ffda-letter-prompts-api-choose-partner-23150.html ChemWerth to Rebuild Quality Systems for Xi’An Libang Pharmaceutical Co. Chinese pharmaceutical company appoints quality expert in response to FDA warning letter Woodbridge, CT, March 11, 2010 – Xi’An Libang Pharmaceutical Co.... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3356870 Thu, 11 Mar 2010 20:00:36 +0100 3356870 http://www.medworm.com/index.php?rid=3356871&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FXxfnPYTAjgA%2Farca-announces-going-concern-opinion-per-nasdaq-rule-5250-b-2-23146.html BROOMFIELD, Colo.--(BUSINESS WIRE)--Mar 11, 2010 - ARCA biopharma, Inc. (NASDAQ: ABIO), a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced, as required by NASDAQ... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3356871 Thu, 11 Mar 2010 19:12:25 +0100 3356871 http://www.medworm.com/index.php?rid=3352475&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F2560m7-KZlQ%2Fnew-thyroid-medicine-works-well-statins-study-shows-23136.html From Newsday (Melville, NY) (March 11, 2010) An experimental thyroid medication lowers cholesterol just as effectively as statins -- the most popularly prescribed cholesterol drugs on the market -- and without many of the bothersome side effects,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3352475 Thu, 11 Mar 2010 13:34:25 +0100 3352475 http://www.medworm.com/index.php?rid=3352476&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F7eU4uRnN5AI%2Fsanofi-aventis-successfully-completes-acquisition-chattem-inc-23137.html - Chattem becomes the U.S. Consumer Healthcare Platform for sanofi-aventis - Paris, France - March 11, 2010 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has completed its acquisition of 100% of Chattem, Inc., which is now a... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3352476 Thu, 11 Mar 2010 12:58:16 +0100 3352476 http://www.medworm.com/index.php?rid=3352477&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FUDjEVHXPTtU%2Fastra-boosts-exposure-torrent-deal-23129.html From Associated Press (March 11, 2010) LONDON -- AstraZeneca PLC announced a supply partnership with India’s Torrent Pharmaceuticals on Thursday, its first such link with a generic drugmaker as it seeks to boost its presence in emerging... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3352477 Thu, 11 Mar 2010 12:45:34 +0100 3352477 http://www.medworm.com/index.php?rid=3352478&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FxkVnwrDVYu4%2Ftransgene-signs-exclusive-option-agreement-development-commercialization-immunotherapy-product-23130.html Parc d’Innovation d’Illkirch, France, March 10, 2010 – Transgene S.A. (Euronext Paris: FR0005175080) today announced the signing of an exclusive option agreement with Novartis for the development and commercialisation... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3352478 Thu, 11 Mar 2010 12:13:33 +0100 3352478 http://www.medworm.com/index.php?rid=3348787&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FoBaOPIQ67TE%2Fquantity-vs-quality-long-term-bone-building-osteoporosis-23112.html Studies find possible links between prolonged bisphosphonate treatments ROSEMONT, Ill., March 10, 2010-Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3348787 Wed, 10 Mar 2010 13:14:36 +0100 3348787 http://www.medworm.com/index.php?rid=3348788&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FDkxQdrPxdBk%2Fteva-announces-appointment-dr-philip-frost-chairman-board-directors-23107.html Jerusalem, Israel, March 9, 2010 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that its Board of Directors received a letter from Mr. Eli Hurvitz indicating that he wishes to be released from his duties at Teva in order to... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3348788 Wed, 10 Mar 2010 12:42:47 +0100 3348788 http://www.medworm.com/index.php?rid=3348789&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F1gVUMBX42oE%2Fphrma-statement-accessing-online-health-23106.html Washington, D.C. (March 9, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President David E. Wheadon issued the following statement regarding patients’ access to reliable health information... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3348789 Wed, 10 Mar 2010 12:42:23 +0100 3348789 http://www.medworm.com/index.php?rid=3348790&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FrlcolqCWAsU%2Fcellzome-announces-second-major-strategic-discovery-alliance-glaxosmithkline-inflammatory-23105.html Collaboration Exploits Cellzome's World-Leading Proteomics Technology in Epigenetics CAMBRIDGE, England and HEIDELBERG, Germany, March 10, 2010/PRNewswire/ -- Cellzome today announced that it has formed a second strategic alliance with... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3348790 Wed, 10 Mar 2010 12:02:48 +0100 3348790 http://www.medworm.com/index.php?rid=3348791&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F846jvOQTHxI%2Fabbott-enhances-pharmaceutical-pipeline-acquisition-facet-biotech-23104.html Provides Promising Biologic Intended to Treat Multiple Sclerosis and Compounds that Complement Abbott's Existing Diverse Oncology Program ABBOTT PARK, Ill. and REDWOOD CITY, Calif., March 9 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) and Facet... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3348791 Wed, 10 Mar 2010 11:46:41 +0100 3348791 http://www.medworm.com/index.php?rid=3348792&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FCqrTlLhk_xs%2Fcatalina-marketing-hires-johnson-amp-johnson-executive-lead-health-care-services-division-23094.html ST. PETERSBURG, FL. March 9, 2010– Catalina Marketing Corporation, the global leader in precision marketing and shopper-driven media, today announced the appointment of Renee Selman as President of its health care division, Catalina... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3348792 Tue, 09 Mar 2010 18:46:14 +0100 3348792 http://www.medworm.com/index.php?rid=3345070&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FuxkKVkegQTI%2Fgsk-ceo-andrew-witty-dedicates-albendazole-facility-nashik-s-global-programme-eliminate-lf-23085.html LONDON, March 8, 2010--GlaxoSmithKline (GSK) CEO Andrew Witty today dedicated a new production facility at its Nashik site in India to the manufacture of albendazole, part of a combination treatment used within the World Health... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3345070 Tue, 09 Mar 2010 13:14:39 +0100 3345070 http://www.medworm.com/index.php?rid=3345071&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F-9YjtqE7IYM%2Fcardiff-university-merck-serono-launch-international-survey-couples-trying-conceive-23084.html • Largest study aimed at understanding the fertility decision-making process of today’s couples trying to conceive • Survey available in twelve languages on www.startingfamilies.com Mumbai, India, March 9, 2010 –... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3345071 Tue, 09 Mar 2010 13:01:26 +0100 3345071 http://www.medworm.com/index.php?rid=3345072&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FW30b3dbZ7T4%2Fexelixis-announces-restructuring-23086.html - Aligning Resources with Late-Stage Compounds XL184, XL147 and XL765 - SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 8, 2010 - Exelixis, Inc. (Nasdaq:EXEL) today announced a restructuring as a consequence of its continued strategy to focus... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3345072 Tue, 09 Mar 2010 13:00:56 +0100 3345072 http://www.medworm.com/index.php?rid=3345073&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fq9hw6-Eu4Yo%2Fnabi-closes-license-deal-glaxosmithkline-23079.html From Associated Press (March 8, 2010) ROCKVILLE, Md. -- Nabi Pharmaceuticals said Monday it closed an option and license agreement for the smoking vaccine candidate NicVAx with GlaxoSmithKline. The deal is potentially worth more than $500 million,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3345073 Tue, 09 Mar 2010 12:17:06 +0100 3345073 http://www.medworm.com/index.php?rid=3345074&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F4_jFsQsGoOU%2Fmylan-rebukes-cites-flaws-bayer-sponsored-mylan-nifedipine-extended-release-bioequivalence-study-23078.html TORONTO, March 9 /CNW Telbec/ - Mylan (Nasdaq: MYL) today reported that it has identified multiple flaws within a purported bioequivalence study sponsored by Bayer Inc. of Canada. The study compared Bayer's antihypertensive Adalat(R) XL(R) tablets,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3345074 Tue, 09 Mar 2010 12:17:05 +0100 3345074 http://www.medworm.com/index.php?rid=3345075&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fd9KhGjTPJeU%2Froche-suspends-arthritis-study-after-deaths-23067.html From Associated Press (March 8, 2010)   BASEL, Switzerland -- Swiss pharmaceutical company Roche Group said Monday it has suspended a late-stage trial for a new rheumatoid arthritis and lupus drug after several patients died from... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3345075 Mon, 08 Mar 2010 15:18:49 +0100 3345075 http://www.medworm.com/index.php?rid=3345076&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FxMNTe9R3QM8%2Froche-biogen-idec-decide-suspend-ocrelizumab-rheumatoid-arthritis-development-programme-hold-23069.html Future of the Ocrelizumab RA clinical programme under evaluation Basel, Switzerland, March 8, 2010--Roche and Biogen Idec announced today their decision to suspend Ocrelizumab treatment of patients in the Rheumatoid Arthritis (RA)... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3345076 Mon, 08 Mar 2010 13:53:13 +0100 3345076 http://www.medworm.com/index.php?rid=3345077&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FZv9V9aEe86o%2Fisis-earns-6-million-milestone-payment-bristol-myers-squibb-bms-pcsk9rx-23068.html CARLSBAD, Calif., March 8, 2010 /PRNewswire via COMTEX/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company (NYSE: BMY) related to the acceptance of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3345077 Mon, 08 Mar 2010 13:52:27 +0100 3345077 http://www.medworm.com/index.php?rid=3337145&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FY5BAvPRCp7w%2Fxenoport-restructures-focus-key-programs-23045.html SANTA CLARA, Calif.--(BUSINESS WIRE)--Mar 5, 2010 - XenoPort, Inc. (Nasdaq:XNPT) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Company's resources... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3337145 Fri, 05 Mar 2010 19:11:18 +0100 3337145 http://www.medworm.com/index.php?rid=3337146&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FzUMhqiwqPdU%2Fjolla-pharmaceutical-announces-termination-merger-agreement-adamis-pharmaceuticals-23039.html SAN DIEGO--(BUSINESS WIRE)--Mar 5, 2010 - La Jolla Pharmaceutical Company (Pink Sheets: LJPC) today announced that La Jolla and Adamis Pharmaceuticals Corporation (OTCBB: ADMP) have agreed to terminate their merger agreement relating to the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3337146 Fri, 05 Mar 2010 17:52:54 +0100 3337146 http://www.medworm.com/index.php?rid=3337147&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FHCsfGNM-GzQ%2Fchay-enterprises-inc-completes-merger-repurposed-developer-ampio-pharmaceuticals-inc-23034.html LITTLETON, Colo., March 4 /PRNewswire-FirstCall/ -- Chay Enterprises, Inc. (OTC:CHYE) (BULLETIN BOARD: CHYE) is pleased to announce today that the company has merged with DMI Life Sciences, Inc to form Ampio Pharmaceuticals, Inc. Ampio... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3337147 Fri, 05 Mar 2010 14:15:16 +0100 3337147 http://www.medworm.com/index.php?rid=3337148&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FY-lN4kzSNbg%2Fpfizer-ceo-gets-12-5-percent-raise-last-year-s-14-9m-23033.html [The Day, New London, Conn.] From Day, The (New London, CT) (March 4, 2010) Mar. 4--As Pfizer Inc. continues a series of layoffs that are expected to total nearly 20,000 by the time its... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3337148 Fri, 05 Mar 2010 13:48:12 +0100 3337148 http://www.medworm.com/index.php?rid=3333544&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FRwcxSp2gVJE%2Fpfizer-bristol-myers-say-clot-meets-goals-23024.html From Associated Press (March 5, 2010) NEW YORK -- Bristol-Myers Squibb Co. and Pfizer Inc. on Thursday said their blood thinner apixaban was more effective than Sanofi-Aventis’ Lovenox in a late stage clinical trial. The study compared the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3333544 Fri, 05 Mar 2010 12:45:33 +0100 3333544 http://www.medworm.com/index.php?rid=3333545&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FhNtBj90QV9k%2Fgrassley-statement-gao-report-fda-office-criminal-investigations-23026.html M E M O R A N D U M TO: Reporters and Editors RE: FDA Criminal Division DA: Thursday, March 4, 2010 Senator Chuck Grassley issued the comment below about a newly released report of the Government Accountability Office regarding the criminal division... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3333545 Fri, 05 Mar 2010 12:37:29 +0100 3333545 http://www.medworm.com/index.php?rid=3333546&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FMJr6K2QF7WQ%2Fabbott-executives-chair-medical-device-lobby-23027.html From Associated Press (March 4, 2010) WASHINGTON -- The medical device industry’s chief advocacy group, AdvaMed, said Thursday an Abbott Laboratories executive will serve as its chairman. James Mazzo is President of Abbott Medical Optics, a... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3333546 Fri, 05 Mar 2010 12:08:23 +0100 3333546 http://www.medworm.com/index.php?rid=3333547&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FZjhNOXOta1c%2Funilife-sanofi-aventis-agree-exclusivity-list-unifill-ready-fill-syringe-23028.html     LEWISBERRY, Pa., March 2 /PRNewswire-FirstCall/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ:UNIS) , today announced that it has agreed to a list of therapeutic drug classes ("Exclusivity List") within which sanofi-aventis... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3333547 Fri, 05 Mar 2010 12:02:46 +0100 3333547 http://www.medworm.com/index.php?rid=3333548&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FMmOJ9tuvElk%2Fmerck-statement-vioxx-judgment-australia-23025.html WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Mar 5, 2010 - Today, the Federal Court in Australia published its judgment in the Peterson case. The Court found against MSD Australia on two claims under Australian statutory provisions. The Court... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3333548 Fri, 05 Mar 2010 11:54:36 +0100 3333548 http://www.medworm.com/index.php?rid=3333549&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FgV5aD_Cqh1I%2Fdistrict-court-upholds-fda-s-grant-5-year-market-exclusivity-vyvanse-r-23020.html PHILADELPHIA, March 4, 2010/PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3333549 Thu, 04 Mar 2010 21:02:41 +0100 3333549 http://www.medworm.com/index.php?rid=3329475&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FFBl7ZAPt5uw%2Fh-lundbeck-s-dk-fourth-quarter-full-year-report-2009-lundbeck-delivers-22-percent-revenue-growth-23007.html COPENHAGEN, March 4, 2010--H. Lundbeck A/S (Lundbeck) announces 2009 results, which meet financial forecasts and continue to show growth in all regions. Full year revenue was DKK 13,747 million and increased 22% at constant exchange rates compared... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329475 Thu, 04 Mar 2010 13:11:47 +0100 3329475 http://www.medworm.com/index.php?rid=3329476&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FlHwqg1PpQXk%2Fnice-appraisal-azacitidine-myelodysplastic-syndromes-23008.html LONDON, March 4, 2010--The National Institute for Health and Clinical Excellence (NICE) is currently appraising the use of azacitidine (Vidaza, Celgene) for myelodysplastic syndromes. In the final draft guidance, published today (4 March 2010), NICE... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329476 Thu, 04 Mar 2010 13:03:14 +0100 3329476 http://www.medworm.com/index.php?rid=3329477&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FXS5lUbg-n0c%2Fbristol-myers-squibb-highlight-strong-pipeline-execution-biopharma-strategy-meeting-investment-22997.html Well-Positioned to Deliver in 2010 and On Track to Execute BioPharma Strategy Provides 2013 Minimum Non-GAAP EPS Guidance Will Present In-Depth Review of Robust, Differentiated Pipeline NEW YORK--(BUSINESS WIRE)--Mar 4, 2010 - During a meeting... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329477 Thu, 04 Mar 2010 12:47:14 +0100 3329477 http://www.medworm.com/index.php?rid=3329478&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fw04LZ6s1XbY%2Fkv-pharmaceutical-subsidiary-pleads-guilty-two-felonies-regarding-oversized-23000.html     Judge Sentences St. Louis-Based Company to Pay $27.6 Million in Fines, Restitution and Forfeitures WASHINGTON, March 2 /PRNewswire-USNewswire/ -- Ethex Corporation, a wholly owned subsidiary of St. Louis-based drug manufacturer, KV... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329478 Thu, 04 Mar 2010 12:36:58 +0100 3329478 http://www.medworm.com/index.php?rid=3329479&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F4s35ezBDLck%2Fwatson-announces-agreement-acquire-u-s-rights-columbia-laboratories-crinone-progesterone-gel-22998.html - Established, patient-preferred infertility treatment - - Expands Watson's Women's Health brand product portfolio - - Preterm birth clinical trials currently underway - - Company acquires 11.2 million shares of Columbia common stock - MORRISTOWN,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329479 Thu, 04 Mar 2010 12:36:35 +0100 3329479 http://www.medworm.com/index.php?rid=3329480&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FfO7yH1dvhJU%2Fcolumbia-laboratories-enters-into-purchase-collaboration-agreement-watson-pharmaceuticals-22999.html Watson to acquire rights to CRINONE® and PROCHIEVE® and 11.2 million shares of common stock for upfront and milestone payments of up to $92.5 million plus royalties Also announces contingent agreements to retire debt Investor conference call... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329480 Thu, 04 Mar 2010 12:23:22 +0100 3329480 http://www.medworm.com/index.php?rid=3329481&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FGwwl1j2HKE4%2Fdanish-lundbeck-launch-two-depression-phase-iii-22980.html From Nordic Business Report (March 3, 2010) 3 March 2010 - Danish pharma company H Lundbeck A/S (CPH: LUN) and its R&D partner Japanese TakedaPharmaceutical Company Ltd (TYO: 4502) said today they will start pivotal clinical phase III... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329481 Wed, 03 Mar 2010 15:32:12 +0100 3329481 http://www.medworm.com/index.php?rid=3329482&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FWpu6HfEusRQ%2Fbristol-myers-squibb-allergan-enter-global-agreement-investigational-neuropathic-pain-medicine-22981.html PRINCETON, N.J. & IRVINE, Calif.--(BUSINESS WIRE)--Mar 3, 2010 - Bristol-Myers Squibb Company (NYSE: BMY) and Allergan , Inc. (NYSE: AGN) today announced a global agreement for the development and commercialization of AGN-209323, a Phase... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329482 Wed, 03 Mar 2010 14:59:55 +0100 3329482 http://www.medworm.com/index.php?rid=3329483&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FIeLQ85-iVNA%2Flundbeck-takeda-finalize-plans-initiate-phase-iii-pivotal-clinical-trials-lu-aa21004-lu-aa24530-22982.html OSAKA, March 3, 2010--H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) today jointly announced the plans for the additional clinical phase III studies on Lu AA21004 and phase III studies on Lu AA24530 in patients with... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329483 Wed, 03 Mar 2010 13:40:34 +0100 3329483 http://www.medworm.com/index.php?rid=3329484&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FOYF6FF6zXFU%2Fteva-announces-favorable-court-ruling-hyzaar-cozaar-litigation-22983.html JERUSALEM--(BUSINESS WIRE)--Mar 2, 2010 - Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the U.S. Court of Appeals for the District of Columbia Circuit has ruled in Teva's favor by overturning a July 31, 2009, district court... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329484 Wed, 03 Mar 2010 12:54:23 +0100 3329484 http://www.medworm.com/index.php?rid=3329485&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FIFdBMxXIWyM%2Ffda-grants-final-approval-flomax-22985.html From Associated Press (March 2, 2010) HAYWARD, Calif. -- Drugmaker Impax Laboratories Inc. said Tuesday the Food and Drug Administration gave final approval to its generic version of the enlarged prostate treatment Flomax. Impax plans to start... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329485 Wed, 03 Mar 2010 11:55:20 +0100 3329485 http://www.medworm.com/index.php?rid=3329486&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F4pvSkUjZJqI%2Fdendreon-rises-fda-says-no-meeting-provenge-22984.html From Associated Press (March 2, 2010) WASHINGTON -- Shares of biotechnology company Dendreon Corp. jumped Tuesday after federal regulators said they don’t plan to hold a public meeting on the company’s prostate cancer treatment, possibly... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329486 Wed, 03 Mar 2010 11:55:17 +0100 3329486 http://www.medworm.com/index.php?rid=3329487&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F1tYOZuvJgwA%2Fnabi-shareholders-approve-deal-glaxo-22986.html From Associated Press (March 2, 2010) ROCKVILLE, Md. -- Nabi Biopharmaceuticals said Tuesday shareholders approved its option and license agreement for the smoking vaccine candidate NicVAx with GlaxoSmithKline. More than 73 percent of Nabi’s... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3329487 Wed, 03 Mar 2010 11:50:57 +0100 3329487 http://www.medworm.com/index.php?rid=3325326&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FgekR-vNCxFs%2Fbristol-myers-squibb-names-lamberto-andreotti-ceo-effective-may-4-james-cornelius-retire-ceo-remain-22968.html NEW YORK--(BUSINESS WIRE)--Mar 2, 2010 - Bristol-Myers Squibb Company (NYSE:BMY) today announced that Lamberto Andreotti, 59, has been designated by the Board of Directors to serve as the company's chief executive officer, effective May 4, when... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3325326 Tue, 02 Mar 2010 21:34:15 +0100 3325326 http://www.medworm.com/index.php?rid=3325327&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F2GKQMnzOolk%2Fabbott-enanta-announce-advancement-hepatitis-c-collaboration-22956.html Initiation of Phase 2 Clinical Trial Investigating Three Individual HCV Antivirals ABBOTT PARK, Ill. and WATERTOWN, Mass., March 2 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) and Enanta Pharmaceuticals announced today the advancement of their... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3325327 Tue, 02 Mar 2010 15:46:27 +0100 3325327 http://www.medworm.com/index.php?rid=3325328&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fi11Rjrw16p8%2Fmed-ad-news-21st-annual-manny-awards-honor-healthcare-advertising-agencies-22955.html MED AD NEWS' 21ST ANNUAL MANNY AWARDS WILL HONOR HEALTHCARE ADVERTISING AGENCIES NEWTOWN, Pa., March 2, 2010 - - On Thursday, April 22, 2010, Med Ad News magazine will host its 21st Annual Manny Awards celebrating creative excellence in... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3325328 Tue, 02 Mar 2010 13:39:13 +0100 3325328 http://www.medworm.com/index.php?rid=3320363&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F7PA6yADxJzw%2Fbaxter-acquire-all-outstanding-equity-apatech-including-actifuse-22947.html DEERFIELD, Ill. and LONDON, U.K., March 1, 2010 – Baxter International Inc. (NYSE:BAX), a global, diversified healthcare company, and ApaTech, a private equity-backed, U.K.-based orthobiologic products company, today announced a... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3320363 Tue, 02 Mar 2010 12:40:55 +0100 3320363 http://www.medworm.com/index.php?rid=3320364&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FNzMC9OxwzIM%2Fwatson-signs-agreement-divest-equity-interest-scinopharm-22948.html Intends to Use Proceeds to Support Business Development, General Business Purposes MORRISTOWN, N.J., March 1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI) today announced that it signed an agreement on February 26, 2010 to divest... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3320364 Tue, 02 Mar 2010 12:25:05 +0100 3320364 http://www.medworm.com/index.php?rid=3320365&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FPnqrtZW_IK0%2Fsupergen-reports-2009-fourth-quarter-year-end-financial-results-22946.html Achieves net income for quarter & year of $2.3 million and $4.7 million, respectively Ends year with over $100 million in cash, cash equivalents & marketable securities DUBLIN, Calif.--(BUSINESS WIRE)--Mar 1, 2010 - SuperGen... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3320365 Mon, 01 Mar 2010 21:22:27 +0100 3320365 http://www.medworm.com/index.php?rid=3320366&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FLLz3Y58KSoQ%2Fosi-pharmaceuticals-confirms-receipt-unsolicited-proposal-astellas-pharma-22941.html - Advises Stockholders to Take No Action at this Time - MELVILLE, N.Y.--(BUSINESS WIRE)--Mar 1, 2010 - OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) today confirmed that it has received an unsolicited proposal from Astellas Pharma Inc. ("Astellas") to... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3320366 Mon, 01 Mar 2010 20:18:39 +0100 3320366 http://www.medworm.com/index.php?rid=3320367&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fv4FPSe9rIiY%2Fstull-stull-amp-brody-announces-investigation-behalf-shareholders-osi-pharmaceuticals-inc-22942.html NEW YORK--(BUSINESS WIRE)--Mar 1, 2010 - Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of OSI Pharmaceuticals, Inc. (“OSI” or the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3320367 Mon, 01 Mar 2010 20:00:54 +0100 3320367 http://www.medworm.com/index.php?rid=3320368&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FlYsdhmMWo00%2Fmerck-announces-robust-integrated-pipeline-more-than-20-medicines-vaccines-late-stage-development-22928.html Integrated pipeline includes potential first-in-class candidates in therapeutic areas including cardiology, diabetes and infectious diseases   WHITEHOUSE STATION, N.J., March 1, 2010 - Merck & Co., Inc. (NYSE:MRK) today announced... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3320368 Mon, 01 Mar 2010 15:33:43 +0100 3320368 http://www.medworm.com/index.php?rid=3320369&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FPI4foz-WDKU%2Fmerck-announces-robust-integrated-pipeline-more-than-20-medicines-vaccines-late-stage-development-22925.html Integrated pipeline includes potential first-in-class candidates in therapeutic areas including cardiology, diabetes and infectious diseases   WHITEHOUSE STATION, N.J., March 1, 2010--Merck & Co., Inc. (NYSE:MRK) today announced its... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3320369 Mon, 01 Mar 2010 14:47:51 +0100 3320369 http://www.medworm.com/index.php?rid=3320370&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FWEy0YWyehJc%2Fastrazeneca-exercises-option-acquire-merck-s-interest-partnership-products-22926.html WHITEHOUSE STATION, N.J., March 1, 2010 – Merck & Co., Inc. announced today that it has been advised by AstraZeneca PLC that it will exercise the option to obtain Merck's interest in AstraZeneca's non-proton pump inhibitor (non-PPI)... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3320370 Mon, 01 Mar 2010 13:27:14 +0100 3320370 http://www.medworm.com/index.php?rid=3320371&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FzCd8B3HwDpk%2Fastrazeneca-exercises-option-acquire-merck-s-interest-partnership-products-22927.html WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Mar 1, 2010 - Merck & Co., Inc. announced today that it has been advised by AstraZeneca PLC that it will exercise the option to obtain Merck's interest in AstraZeneca's non-proton pump inhibitor... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3320371 Mon, 01 Mar 2010 13:25:21 +0100 3320371 http://www.medworm.com/index.php?rid=3317391&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FBLJ0Ssfx_Rw%2Fastellas-pharma-inc-offers-acquire-osi-pharmaceuticals-52-00-per-share-cash-22918.html Offer is premium of over 40% to closing stock price of OSI and 53% premium over three-month average Astellas to build a world-class oncology platform Astellas expects to invest in OSI's business and employees TOKYO, March 1 /PRNewswire-FirstCall/ --... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3317391 Mon, 01 Mar 2010 12:04:55 +0100 3317391 http://www.medworm.com/index.php?rid=3317392&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FE-8ufGOoatQ%2Fmerck-kgaa-millipore-announce-transaction-22917.html - Merck to acquire all outstanding Millipore shares for US$ 107 per share in cash, creating a world-class partner for the life science sector - Agreed transaction valued at approximately EUR 5.3 billion (US$ 7.2 billion) - Combination will create a... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3317392 Mon, 01 Mar 2010 11:42:37 +0100 3317392 http://www.medworm.com/index.php?rid=3313496&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Ff5vn2dGhCDM%2Fconjuchem-files-restructuring-22908.html - Felix J. Baker Resigns as Director - MONTREAL, Feb. 26 /CNW/ - ConjuChem Biotechnologies Inc. (TSX: CJB) ("ConjuChem" or the "Company") announced today that the Superior Court of Québec (Commercial Division) has granted an initial order to... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3313496 Fri, 26 Feb 2010 20:59:00 +0100 3313496 http://www.medworm.com/index.php?rid=3313497&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FJMxhNQW-PyE%2Fims-health-announces-completion-acquisition-affiliates-tpg-cpp-investment-board-22899.html NORWALK, Conn.--(BUSINESS WIRE)--Feb 26, 2010 - IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the completion of its acquisition by entities created by... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3313497 Fri, 26 Feb 2010 17:55:48 +0100 3313497 http://www.medworm.com/index.php?rid=3309601&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F0M7440KnlSc%2Fphilippines-lower-prices-more-medicines-22884.html From Associated Press (February 26, 2010) MANILA, Philippines -- The Philippine government announced price cuts Friday on 97 medicines that officials say will result in at least 1 billion pesos ($21.7 million) in annual savings for Filipinos. The... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309601 Fri, 26 Feb 2010 12:46:18 +0100 3309601 http://www.medworm.com/index.php?rid=3309602&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F2CiMl7u5Te8%2Fregulus-glaxo-work-hepatitis-c-22886.html From Associated Press (February 25, 2010) NEW YORK -- Drugmaker Regulus Therapeutics LLC said Thursday it is expanding a partnership with GlaxoSmithKline, and will begin researching new treatments for hepatitis C. Regulus said it will identify a... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309602 Fri, 26 Feb 2010 12:40:05 +0100 3309602 http://www.medworm.com/index.php?rid=3309603&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FMxL3_BtYokw%2Fkv-close-ethex-unit-plead-guilty-charges-22887.html From Associated Press (February 25, 2010) NEW YORK -- KV Pharmaceutical Co. said Thursday it will shut down it Ethex generic drug unit and plead guilty to criminal charges alleging Ethex failed to promptly inform regulators about dangerous... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309603 Fri, 26 Feb 2010 12:25:06 +0100 3309603 http://www.medworm.com/index.php?rid=3309604&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FfuZLKV1kdwU%2Fpfizer-s-ringo-retire-senior-vp-post-22888.html From Associated Press (February 25, 2010) NEW YORK -- Pfizer Inc. said Thursday that William Ringo will retire as a senior vice president at the drug maker. Ringo will be replaced April 30 by Kristin Peck, who will become senior vice president of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309604 Fri, 26 Feb 2010 12:05:55 +0100 3309604 http://www.medworm.com/index.php?rid=3309605&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fqvl5c654u6I%2Flilly-settlement-fund-mt-mental-health-services-22885.html From Associated Press (February 26, 2010) HELENA, Mont. -- The state attorney general's office has settled a lawsuit with a major pharmaceutical company and will use most of the proceeds to pay for mental health services and programs in... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309605 Fri, 26 Feb 2010 11:58:05 +0100 3309605 http://www.medworm.com/index.php?rid=3309606&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FkP-MJofpui8%2Fking-pharmaceuticals-reports-full-year-fourth-quarter-2009-financial-results-22860.html BRISTOL, TN--(Marketwire - February 25, 2010) - King Pharmaceuticals, Inc. (NYSE: KG<http://www.marketwire.com/mw/stock.jsp?Ticker=KG>) -- FULL YEAR 2009 REVENUE INCREASED 14% TO $1.78 BILLION -- 2009 CASH FLOW FROM OPERATIONS $431 MILLION,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309606 Thu, 25 Feb 2010 12:34:58 +0100 3309606 http://www.medworm.com/index.php?rid=3309607&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F4pQYbgSLQh4%2Fpfizer-says-fda-oks-updated-infection-vaccine-22861.html From Associated Press (February 24, 2010) WASHINGTON -- Pfizer said Wednesday the Food and Drug Administration has approved an updated version of its best-selling infection vaccine for infants and children. Prevnar 13 is intended to reduce the risk... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309607 Thu, 25 Feb 2010 10:48:55 +0100 3309607 http://www.medworm.com/index.php?rid=3309608&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F1ufAQ_bNSvA%2Fpanel-recommends-annual-flu-vaccinations-all-22862.html From Associated Press (February 24, 2010) ATLANTA -- A government panel is now recommending that virtually all Americans get a flu shot each year, starting this fall. The Advisory Committee on Immunization Practices had gradually been expanding... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309608 Thu, 25 Feb 2010 10:42:22 +0100 3309608 http://www.medworm.com/index.php?rid=3309609&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FvauDh_F9ZCg%2Fcanon-communications-launch-medical-electronics-design-events-u-s-japan-china-2010-22872.html DesignMed series targets worldwide $60 billion sector LOS ANGELES--(BUSINESS WIRE)--Feb 23, 2010 - Canon Communications today announced that in 2010 it will launch three DesignMed events dedicated to the constantly evolving and highly innovative... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309609 Wed, 24 Feb 2010 21:02:53 +0100 3309609 http://www.medworm.com/index.php?rid=3309610&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FuEdTnm9AHSE%2Farena-weight-loss-under-fda-review-22863.html From Associated Press (February 24, 2010) SAN DIEGO -- Federal regulators are reviewing Arena Pharmaceuticals’ application for a weight-loss drug, the biotechnology company said Wednesday. The company said it does not have a target date for... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309610 Wed, 24 Feb 2010 15:42:56 +0100 3309610 http://www.medworm.com/index.php?rid=3309611&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FSBlaMpcpGrM%2Fpfizer-says-fda-oks-updated-infection-vaccine-22864.html From Associated Press (February 24, 2010) WASHINGTON -- Pfizer says the Food and Drug Administration has approved an updated version of its best-selling infection vaccine for children. Prevnar 13 is intended to reduce the risk of infection by... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309611 Wed, 24 Feb 2010 15:34:49 +0100 3309611 http://www.medworm.com/index.php?rid=3309612&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FsAfWDHMZb8E%2Fh-lundbeck-s-dk-lundbeck-expands-agreement-teva-include-marketing-azilect-selected-asian-countries-22865.html Lundbeck expands the agreement with Teva to include marketing of Azilect® in selected Asian countries COPENHAGEN, Feb. 24, 2010-H. Lundbeck A/S (Lundbeck) today announced it had expanded the agreement with Teva Pharmaceutical Industries Ltd.... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309612 Wed, 24 Feb 2010 15:23:45 +0100 3309612 http://www.medworm.com/index.php?rid=3309613&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FAHtGpHFxATQ%2Fala-woman-wins-9-45-million-wyeth-hormone-suit-22866.html [The Philadelphia Inquirer] From Philadelphia Inquirer (PA) (February 23, 2010) Feb. 23--A Philadelphia jury yesterday ordered Pfizer Inc.’s Wyeth unit to pay $9.45 million to an Alabama... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309613 Wed, 24 Feb 2010 15:23:19 +0100 3309613 http://www.medworm.com/index.php?rid=3309614&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FTVU7LVisPjk%2Fshire-provides-update-biologics-license-application-bla-filing-replagal-agalsidase-alfa-u-s-food-22867.html CAMBRIDGE, Massachusetts, February 24, 2010/PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces it has received Fast Track designation from the FDA for REPLAGAL(R) (agalsidase... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309614 Wed, 24 Feb 2010 15:18:48 +0100 3309614 http://www.medworm.com/index.php?rid=3309615&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FcnOe9DEJo8Y%2Ffda-warns-heart-risk-hiv-combination-22868.html From Associated Press (February 23, 2010) WASHINGTON -- The Food and Drug Administration issued a warning Tuesday about potential heart risks when combining two HIV drugs. The agency said preliminary data suggest Roche ’s Invirase and Abbott... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309615 Wed, 24 Feb 2010 15:18:46 +0100 3309615 http://www.medworm.com/index.php?rid=3309616&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FFP0QRDElrH8%2Fosi-4q-profit-drops-but-tarceva-sales-rise-22869.html From Associated Press (February 24, 2010) MELVILLE, N.Y. -- OSI Pharmaceuticals Inc. said Tuesday its fourth-quarter profit plunged a year after the company received a hefty non-cash gain, but royalties from its cancer drug Tarceva continued pushing... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309616 Wed, 24 Feb 2010 14:35:43 +0100 3309616 http://www.medworm.com/index.php?rid=3309617&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FTskRaNXLMRw%2Ffda-places-shire-application-fast-track-22870.html From Associated Press (February 24, 2010) British drug maker Shire PLC said Wednesday its application for approval of the Fabry disease treatment Replagal has received a "fast track" designation from the U.S. Food and Drug Administration. Replagal... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309617 Wed, 24 Feb 2010 14:15:15 +0100 3309617 http://www.medworm.com/index.php?rid=3309618&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FNeJbAPgz3Rw%2Fmillipore-corporation-confirms-evaluating-strategic-alternatives-22871.html BILLERICA, Mass.--(BUSINESS WIRE)--Feb 24, 2010 - Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today confirmed that its Board of Directors is evaluating strategic... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309618 Wed, 24 Feb 2010 14:00:51 +0100 3309618 http://www.medworm.com/index.php?rid=3309619&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F-v8cqxAkFjQ%2Finvirase-saquinavir-ongoing-safety-review-clinical-trial-data-possible-association-abnormal-heart-22873.html Invirase (saquinavir): Ongoing safety review of clinical trial data Audience: HIV/AIDS and cardiological healthcare professionals, patients ROCKVILLE, Md., Feb. 23, 2010-FDA notified healthcare professionals and patients that it is reviewing... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309619 Wed, 24 Feb 2010 13:33:43 +0100 3309619 http://www.medworm.com/index.php?rid=3309620&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fvjv3c9qByLE%2Ffda-safety-communication-ongoing-safety-review-invirase-saquinavir-possible-association-abnormal-22874.html Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary   Safety Announcement [02-23-2010] The U.S. Food and Drug Administration (FDA) is reviewing clinical trial data about... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3309620 Wed, 24 Feb 2010 12:25:52 +0100 3309620 http://www.medworm.com/index.php?rid=3300387&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F_HEdL6fk7q4%2Ficahn-nominates-4-genzyme-slate-22824.html NEW YORK, Feb. 23 /PRNewswire/ -- Carl Icahn announced today that he and his affiliated entities notified Genzyme Corporation (NASDAQ:GENZ) on Friday, February 19, 2010, of their intention to nominate 4 director candidates at the 2010 annual meeting... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3300387 Tue, 23 Feb 2010 18:37:30 +0100 3300387 http://www.medworm.com/index.php?rid=3300388&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FQvyEWnghGf8%2Flilly-merck-pfizer-join-forces-accelerate-research-improve-lung-gastric-cancers-asia-22811.html Publicly Available Genomic Database of Profiled Tumor Samples to Provide a Resource for Biomedical Researchers Worldwide INDIANAPOLIS, WHITEHOUSE STATION, N.J. & NEW YORK--(BUSINESS WIRE)--Feb 23, 2010 - Eli Lilly and Company, Merck (also known... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3300388 Tue, 23 Feb 2010 15:39:02 +0100 3300388 http://www.medworm.com/index.php?rid=3300389&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FLlqzba6s4TA%2Fpharmaceutical-industry-support-not-desirable-but-frequently-accepted-residency-program-directors-22812.html CHICAGO, Feb. 22, 2010—Most directors of internal medicine residency training programs would prefer not to accept pharmaceutical support for the residencies they oversee, but more than half report doing so, according to an article in the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3300389 Tue, 23 Feb 2010 15:28:53 +0100 3300389 http://www.medworm.com/index.php?rid=3300390&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F6mpEnT_m0pI%2Fviamet-teams-up-novartis-22813.html [The News And Observer, Raleigh, N.C.] From News & Observer (Raleigh, NC) (February 23, 2010) Feb. 23--A small Morrisville drug company co-founded by UNC Chapel Hill Chancellor Holden Thorp has signed a development... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3300390 Tue, 23 Feb 2010 15:03:13 +0100 3300390 http://www.medworm.com/index.php?rid=3300391&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FZuTLk3hK44o%2Ffda-reviews-avandia-safety-data-22814.html From UPI Science News (February 23, 2010) The U.S. Food and Drug Administration says it is reviewing data from a long-term study concerning possible cardiovascular risks with the drug Avandia. The FDA’s announcement follows a Saturday report... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3300391 Tue, 23 Feb 2010 15:03:08 +0100 3300391 http://www.medworm.com/index.php?rid=3300392&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FMgXZVlJjoLs%2Feon-labs-pays-3-5-million-settle-false-claims-act-allegations-concerning-reimbursement-claims-less-22815.html BOSTON, Feb. 22, 201- - The Department of Justice and the U.S. Attorney’s Office in Boston announced a $3.5 million settlement today with drug manufacturer Eon Labs, Inc. (Eon), a subsidiary of Sandoz, Inc., which is in turn a subsidiary... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3300392 Tue, 23 Feb 2010 14:42:54 +0100 3300392 http://www.medworm.com/index.php?rid=3300393&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FpmPpIRgyJX8%2Favandia-fallout-could-hit-triangle-22816.html [The News And Observer, Raleigh, N.C.] From News & Observer (Raleigh, NC) (February 23, 2010) Feb. 23--The firestorm over the safety of GlaxoSmithKline’s diabetes drug Avandia could hurt profit at one of... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3300393 Tue, 23 Feb 2010 14:18:58 +0100 3300393 http://www.medworm.com/index.php?rid=3296735&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FQst7Y4S3aSQ%2Favandia-rosiglitazone-fda-reviewing-large-long-term-clinical-study-possible-risks-cardiovascular-22810.html Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety Audience: Endocrinology, cardiology healthcare professionals, patients ROCKVILLE, Md., Feb. 22, 2010-FDA notified healthcare professional and patients that it is reviewing the primary... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3296735 Tue, 23 Feb 2010 13:55:21 +0100 3296735 http://www.medworm.com/index.php?rid=3296736&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F4xLb_fiyWRI%2Fgardasil-approved-health-canada-males-prevent-genital-warts-22808.html KIRKLAND, QC, Feb. 23 /CNW Telbec/ - Today, Merck announced that Health Canada has approved GARDASIL(R) (Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Recombinant Vaccine) for boys and men nine through 26 years of age for the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3296736 Tue, 23 Feb 2010 13:55:11 +0100 3296736 http://www.medworm.com/index.php?rid=3296737&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FTiu8k8iq8tg%2Ffy2009-merck-kgaa-revenues-increase-2-1-7-7-billion-22809.html 2009 Sales: Rebif +15% to € 1,537 million, Erbitux +23% to € 697 million Liquid Crystals FY2009 return on sales (ROS) at 31.0% Merck proposes dividend of € 1 per share Darmstadt, February 23, 2010 - Merck KGaA announced today... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3296737 Tue, 23 Feb 2010 13:40:18 +0100 3296737 http://www.medworm.com/index.php?rid=3296738&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fjr2oMIkQiXk%2Fus-doctor-pleads-guilty-research-fraud-22799.html From Associated Press (February 23, 2010) BOSTON -- A doctor accused of faking research for a dozen years in published studies that suggested after-surgery benefits from painkillers including Vioxx and... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3296738 Tue, 23 Feb 2010 12:50:35 +0100 3296738 http://www.medworm.com/index.php?rid=3296739&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FFWDGftF64I8%2Fus-agrees-pay-3-5-settlement-22800.html From Associated Press (February 23, 2010) BOSTON -- Federal prosecutors say a New Jersey pharmaceutical company has agreed to pay $3.5 million to settle allegations that it claimed its heart drug was... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3296739 Tue, 23 Feb 2010 12:44:57 +0100 3296739 http://www.medworm.com/index.php?rid=3296740&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FJBzpJcqfiUY%2Fmerck-makes-fourth-quarter-net-profit-78-million-22801.html From Associated Press (February 23, 2010) FRANKFURT -- German drug maker Merck KGaA said Tuesday it made a net profit in the fourth quarter, compared with a loss a year ago, as revenue rose... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3296740 Tue, 23 Feb 2010 12:30:32 +0100 3296740 http://www.medworm.com/index.php?rid=3296741&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FK0UyjcA22xk%2Froche-genentech-report-avastin-study-failure-22802.html From Associated Press (February 23, 2010) NEW YORK -- Genentech said Tuesday the combination of its blockbuster cancer drug Avastin and Xeloda did not meet a late-stage study goal of extending the lives of advanced stomach cancer patients. The... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3296741 Tue, 23 Feb 2010 12:20:50 +0100 3296741 http://www.medworm.com/index.php?rid=3296742&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F3sFgsOBMjGw%2Ffda-complete-review-amgen-s-prolia-july-22786.html From Associated Press (February 22, 2010) NEW YORK -- The Food and Drug Administration will take about five more months to complete a review of Amgen Inc.’s bone drug Prolia , keeping the biotechnology company’s potential blockbuster... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3296742 Mon, 22 Feb 2010 16:38:26 +0100 3296742 http://www.medworm.com/index.php?rid=3296743&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FpzvbwsMgKWs%2Fgenzyme-faces-proxy-challenge-icahn-22780.html From Associated Press (February 22, 2010) NEW YORK -- Genzyme Corp. said Monday that activist investor Carl Icahn intends to nominate himself along with three other people to the biotechnology company’s board of directors. Genzyme said it will... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3296743 Mon, 22 Feb 2010 15:20:23 +0100 3296743 http://www.medworm.com/index.php?rid=3296744&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F8eE_FjaUVQw%2Fgenzyme-receives-notice-icahn-partners-nomination-directors-22781.html CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 22, 2010 - Genzyme Corporation (NASDAQ: GENZ), a diversified, global biotechnology company, announced today that it has received notice from Icahn Partners LP and certain of its affiliates of their intention... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3296744 Mon, 22 Feb 2010 15:06:04 +0100 3296744 http://www.medworm.com/index.php?rid=3296745&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FLhHs0SUc4tk%2Fcase-cost-cardinal-1-million-22782.html : 'Rogue Workers' responsible for latest problem [The Columbus Dispatch, Ohio] (February 20, 2010) Feb. 20--Cardinal Health has agreed to pay a $1 million settlement "for failing to account for large amounts... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3296745 Mon, 22 Feb 2010 14:05:59 +0100 3296745 http://www.medworm.com/index.php?rid=3293256&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FmaS3D5eVIyo%2Fretin-researcher-albert-kligman-dies-22771.html From Associated Press (February 21, 2010) PHILADELPHIA -- Dermatologist Albert M. Kligman, whose research led to discoveries including the acne and wrinkle drug Retin-A but whose pioneering work was overshadowed by his experiments... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3293256 Mon, 22 Feb 2010 12:37:18 +0100 3293256 http://www.medworm.com/index.php?rid=3293257&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FLjI-7rSp9ug%2Fbaucus-grassley-release-finance-committee-report-diabetes-avandia-express-concern-fda-s-role-22772.html WASHINGTON, Feb. 20, 2010-- – Senator Max Baucus, Chairman of the Committee on Finance, and Senator Chuck Grassley, Ranking Member, today released a committee report based on a twoyear inquiry of the diabetes drug Avandia. The senators also... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3293257 Mon, 22 Feb 2010 12:28:53 +0100 3293257 http://www.medworm.com/index.php?rid=3293258&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FBc6Uv3XcE10%2Fregulatory-science-update-fda-international-serious-adverse-events-consortium-complete-third-data-22773.html Data focus on genetic basis of drug-induced liver injury and serious skin reaction ROCKVILLE, Md., Feb. 19, 2010--The U.S. Food and Drug Administration and the International Serious Adverse Event Consortium (SAEC) today announced the third release... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3293258 Mon, 22 Feb 2010 12:13:10 +0100 3293258 http://www.medworm.com/index.php?rid=3293259&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FtlXeloOoTWU%2Ffda-informs-eisai-medical-research-misleading-aricept-tv-ads-22774.html ROCKVILLE, Md., Feb. 18, 2010--The FDA has posted on its website a letter regarding two television ads for the Alzheimer’s disease drug Aricept. The agency said the ads are misleading because they overstate the... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3293259 Mon, 22 Feb 2010 12:12:50 +0100 3293259 http://www.medworm.com/index.php?rid=3293260&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FahH2yOYJe9k%2Ffda-announces-boxed-warning-exjade-22775.html ROCKVILLE, Md., Feb. 18, 2010--Novartis Oncology and FDA notified healthcare professionals about recent changes in the Prescribing Information (PI) for Exjade, indicated for the treatment of chronic iron overload due to blood transfusions... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3293260 Mon, 22 Feb 2010 12:00:51 +0100 3293260 http://www.medworm.com/index.php?rid=3293261&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FOlgR80BeE_c%2Fsenate-report-avandia-maker-knew-cardiac-risks-22770.html From Associated Press (February 21, 2010) NEW YORK -- A Senate report said Saturday that drug maker GlaxoSmithKline knew of possible heart attack risks tied to Avandia, its diabetes medication,... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3293261 Mon, 22 Feb 2010 11:45:34 +0100 3293261 http://www.medworm.com/index.php?rid=3289792&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FsEvYApWiNJo%2Fj-amp-j-partner-says-eu-rejecting-skin-infection-22749.html From Associated Press (February 19, 2010) BASEL, SWITZERLAND -- Johnson & Johnson ’s Swiss partner in developing a long-awaited drug for MRSA and other dangerous skin infections says European regulators won’t approve it. Basilea... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3289792 Fri, 19 Feb 2010 15:25:16 +0100 3289792 http://www.medworm.com/index.php?rid=3289793&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fs3wW_35KpJQ%2Fsepracor-announces-new-management-changes-plans-merger-dainippon-sumitomo-pharma-america-22745.html MARLBOROUGH, Mass.--(BUSINESS WIRE)--Feb 19, 2010 - Sepracor Inc. and Dainippon Sumitomo Pharma Co., Ltd. (DSP) today announce the resignation of Adrian Adams as President and Chief Executive Officer and Director of Sepracor and as Executive Officer... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3289793 Fri, 19 Feb 2010 14:26:35 +0100 3289793 http://www.medworm.com/index.php?rid=3289794&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F6WLPRdg8nUU%2Fj-amp-j-changing-bonus-plan-reward-performance-more-22746.html From Associated Press (February 18, 2010) TRENTON, N.J. -- Thousands of Johnson & Johnson employees will get lower bonuses next year, due to an overhaul of its bonus program meant to make the extra payments more uniform across the sprawling... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3289794 Fri, 19 Feb 2010 14:11:57 +0100 3289794 http://www.medworm.com/index.php?rid=3289795&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F_HiuIBwUQv4%2Froche-s-rituxan-gets-us-ok-another-cancer-22747.html From Associated Press (February 18, 2010) WASHINGTON -- Genentech’s blockbuster blood cancer drug Rituxan has been approved for a new use by the Food and Drug Administration. The FDA says Genentech, the biotech unit of Swiss drug maker Roche... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3289795 Fri, 19 Feb 2010 14:00:46 +0100 3289795 http://www.medworm.com/index.php?rid=3289796&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FjlpdnOzEf-M%2Ffda-issues-warning-4-widely-asthma-22748.html From Associated Press (February 18, 2010) WASHINGTON -- The government is taking steps to curb use of some long-acting asthma drugs taken by millions, issuing safety restrictions Thursday to lower an uncommon but potentially life-threatening risk... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3289796 Fri, 19 Feb 2010 14:00:07 +0100 3289796 http://www.medworm.com/index.php?rid=3286072&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FjkelknsHiik%2Ffda-cancer-approval-rate-highlighted-jnci-22743.html Agency Analysis: More than 50 new cancer indications approved over a 32-month period SILVER SPRING, Md., Feb. 18 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration's Office of Oncology Drug Products approved more than 50 new... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3286072 Fri, 19 Feb 2010 13:00:48 +0100 3286072 http://www.medworm.com/index.php?rid=3286073&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F-KaIpiCy31Q%2Fgsk-statement-fda-s-proposed-label-revisions-some-asthma-medicines-22744.html RESEARCH TRIANGLE PARK, N.C., Feb. 18 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) is reviewing label changes proposed today by the US Food and Drug Administration (FDA) for asthma medications containing long-acting beta-agonists (LABAs),... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3286073 Fri, 19 Feb 2010 13:00:44 +0100 3286073 http://www.medworm.com/index.php?rid=3286074&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FInDX9ZmzwAU%2Fexcellent-results-transformational-year-shire-core-product-sales-up-25-22737.html DUBLIN, February 19, 2010/PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the year to December 31, 2009.   Financial Highlights   ... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3286074 Fri, 19 Feb 2010 12:51:01 +0100 3286074 http://www.medworm.com/index.php?rid=3286075&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2Fc_Z0B0nkbYA%2Foncothyreon-announces-sale-oncothyreon-canada-22736.html SEATTLE, Feb. 18 /PRNewswire-FirstCall/ -- Oncothyreon Inc. (NASDAQ:ONTY) today announced that it has entered into an arrangement agreement (the "Arrangement") pursuant to which it will sell its interests in Oncothyreon Canada Inc., an indirect... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3286075 Thu, 18 Feb 2010 21:17:18 +0100 3286075 http://www.medworm.com/index.php?rid=3286076&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FVOmtiZUF9rw%2Fexjade-deferasirox-boxed-warning-changes-re-risk-renal-impairment-failure-hepatic-impairment-22729.html ROCKVILLE, Md., Feb. 18, 2010--Novartis Oncology and FDA notified healthcare professionals about recent changes in the Prescribing Information (PI) for Exjade, indicated for the treatment of chronic iron overload due to blood transfusions... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3286076 Thu, 18 Feb 2010 19:26:42 +0100 3286076 http://www.medworm.com/index.php?rid=3286077&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2F5R3Ns_amwV4%2Fregeneron-bayer-eye-meet-study-goal-22720.html From Associated Press (February 18, 2010) NEW YORK -- Regeneron Pharmaceuticals Inc. and Bayer HealthCare AG said Thursday their developing VEGF Trap-Eye drug met key vision improvement goals in a midstage study. The drug is aimed at improving... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3286077 Thu, 18 Feb 2010 13:59:09 +0100 3286077 http://www.medworm.com/index.php?rid=3286078&cid=s_36540_34_f&fid=36540&url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FLvGeKwNNXWA%2Fdynavax-glaxosmithkline-select-clinical-candidate-endosomal-tlr-inhibitor-program-22718.html BERKELEY, CA, Feb 18, 2010 (MARKETWIRE via COMTEX News Network) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the selection of a candidate for clinical development in its endosomal Toll-like Receptor (TLR) inhibitor... (Source: Drugs.com - Pharma News) Drugs.com - Pharma News news http://www.medworm.com/rss/comments.php?id=3286078 Thu, 18 Feb 2010 13:26:44 +0100 3286078